Peter Xu
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Peter Xu
Peter Xu is recorded as CFO at Estrella Immunopharma, Inc. (ESLA). Estrella Immunopharma, Inc. reported in an 8-K filed October 5, 2023 that Peter Xu was appointed Chief Financial Officer, effective September 29, 2023.
“On September 29, 2023, New Estrella entered into a new employment agreement with Mr. Xu, setting forth the terms of his employment as New Estrella's Chief Financial Officer.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
2023-09-29–present
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Estrella Immunopharma, Inc.
Other people whose current roles at this company are on record from its filings.
- Dr. Cheng Liu CEO
- Jianwei Li CEO
- Hong Zhang Chairman, Board Member
- James Long Board Member
- Jia Dengyao Board Member
- Tao Jiang Board Member
- Weston Twigg Board Member
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.